An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-12-13
DOI
10.1016/j.apsb.2020.12.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2020) Hend Abdelrasoul et al. Nature Communications
- Microtiter plate-based antibody-competition assay to determine binding affinities and plasma/blood stability of CXCR4 ligands
- (2020) Mirja Harms et al. Scientific Reports
- The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
- (2019) Eva M. García-Cuesta et al. Frontiers in Endocrinology
- Small molecule and peptide-based CXCR4 modulators as therapeutic agents. A patent review for the period from 2010 to 2018
- (2019) Yesim A Tahirovic et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- CXCR4 involvement in neurodegenerative diseases
- (2018) Luke W. Bonham et al. Translational Psychiatry
- Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients
- (2018) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Eosinophils Target Therapy for Severe Asthma: Critical Points
- (2018) L. Brussino et al. Biomed Research International
- A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
- (2017) Z Xiang et al. ONCOGENE
- Evaluation of EPI-X4 as a urinary peptide biomarker for diagnosis and prognosis of late acute GvHD
- (2016) J A Müller et al. BONE MARROW TRANSPLANTATION
- CXCR4 signaling in health and disease
- (2016) Tommaso Pozzobon et al. IMMUNOLOGY LETTERS
- Proteolytic processing of human serum albumin generates EPI-X4, an endogenous antagonist of CXCR4
- (2016) Onofrio Zirafi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes
- (2016) G.C.P. van Zundert et al. JOURNAL OF MOLECULAR BIOLOGY
- Atopic dermatitis
- (2016) Stephan Weidinger et al. LANCET
- CXCR4 inhibitor attenuates ovalbumin-induced airway inflammation and hyperresponsiveness by inhibiting Th17 and Tc17 cell immune response
- (2016) HUILONG CHEN et al. Experimental and Therapeutic Medicine
- CXCL12 Signaling Is Essential for Maturation of the Ventricular Coronary Endothelial Plexus and Establishment of Functional Coronary Circulation
- (2015) Susana Cavallero et al. DEVELOPMENTAL CELL
- Eosinophils in mucosal immune responses
- (2015) J Travers et al. Mucosal Immunology
- EPI-X4, a novel endogenous antagonist of CXCR4
- (2015) Christian Buske et al. Oncotarget
- Discovery and Characterization of an Endogenous CXCR4 Antagonist
- (2015) Onofrio Zirafi et al. Cell Reports
- In vivozebrafish assays for analyzing drug toxicity
- (2014) Demetrio Raldúa et al. Expert Opinion on Drug Metabolism & Toxicology
- An Important Role of the SDF-1/CXCR4 Axis in Chronic Skin Inflammation
- (2014) Silvana Zgraggen et al. PLoS One
- An Antedrug of the CXCL12 Neutraligand Blocks Experimental Allergic Asthma without Systemic Effect in Mice
- (2013) François Daubeuf et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CXCR4 Negatively Regulates Keratinocyte Proliferation in IL-23-Mediated Psoriasiform Dermatitis
- (2013) Tomonori Takekoshi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Akt signalling in health and disease
- (2011) Ingeborg Hers et al. CELLULAR SIGNALLING
- The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents
- (2011) M. G. Morash et al. Disease Models & Mechanisms
- Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo
- (2011) Vincent Gasparik et al. ACS Medicinal Chemistry Letters
- Chemokine (C-X-C Motif) Ligand 12/Stromal Cell-Derived Factor-1 Is Associated With Leukocyte Recruitment in Asthma
- (2010) María Cristina Negrete-García et al. CHEST
- Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma
- (2010) T. M. Doyle et al. EUROPEAN RESPIRATORY JOURNAL
- Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
- (2010) B. Wu et al. SCIENCE
- Innate Cells and T Helper 2 Cell Immunity in Airway Inflammation
- (2009) Nora A. Barrett et al. IMMUNITY
- Pathogenesis of Asthma
- (2008) STEPHEN T. HOLGATE CLINICAL AND EXPERIMENTAL ALLERGY
- Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
- (2008) Muriel Hachet-Haas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12
- (2008) C. T. Veldkamp et al. Science Signaling
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now